VNDA

VANDA PHARMACEUTICALS INC

VNDA·921659108·US·Common Stock·Healthcare - Biotechnology-13D/G

VNDA (VANDA PHARMACEUTICALS INC) is held by 106 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($50.3M), RENAISSANCE TECHNOLOGIES LLC ($26M), STATE STREET CORP ($20.8M). Net institutional sentiment: Mixed.

106
Holders
Avg rating(24 Elite)
$260M
Total Value
64% (116)
Fund Consensus
70 buying - 39 selling
VNDASmart Money Verdict
View all
Held by 106 funds
24 elite
Who's Trading
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.1%May 12, 2026
ActivistBPBlackRock Portfolio Management LLC4.2%Apr 29, 2026
InsiderDCDuncan Charles CliffVest 57K shApr 22, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderPHPolymeropoulos Mihael HristosSell $1.3MMar 2, 2026
InsiderBGBirznieks GuntherSell $351KMar 2, 2026
InsiderMPMoran Kevin PatrickSell $351KMar 2, 2026
InsiderWTWilliams TimothySell $351KMar 2, 2026
InsiderWJWijkstrom JoakimSell $255KMar 2, 2026
InsiderHTHonore TageSell $241KFeb 23, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
7.3M(-6.4%)$50.3M0.0%+30.55%
0
Increased
3.8M(+11.2%)$26M0.0%-43.01%
32
Increased
3M(+138.7%)$20.8M0.0%-1.65%
46
New
2.5M$17.1M0.0%-20.41%
39
Increased
1.9M(+12.0%)$13M0.0%+23.13%
31
Decreased
1.8M(-16.4%)$12.2M0.0%+4.12%
0
Increased
1.6M(+155.8%)$11.1M0.0%-6.78%
45
Increased
1.4M(+3.7%)$10M0.0%-56.98%
29
Increased
1.4M(+42.8%)$9.7M0.0%-3.62%
37
Increased
1.2M(+65.0%)$8.1M0.0%-15.89%
40
New
1M$7M0.0%-20.41%
38
Increased
838,233(+105.3%)$5.8M0.0%-4.49%
44
New
633,354$4.4M0.0%-20.41%
37
New
596,002$4.1M0.0%-20.41%
37
Increased
575,389(+3.8%)$4M0.0%-33.35%
28
Increased
551,770(+10.2%)$3.8M0.0%-61.52%
29
Increased
450,981(+5.1%)$3.1M0.0%-64.16%
28
Decreased
440,794(-25.7%)$3M0.0%+22.52%
0
New
387,964$2.7M0.0%-20.41%
36
Decreased
376,858(-49.3%)$2.6M0.0%+12.38%
0

Showing 1-20 of 116

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used